The WHO Global action plan on epilepsy and other neurological disorders
Matilde Leonardi, Director of Neurology, Public Health, Disability Unit and Coma Research Centre and Director of the Italian WHO Collaborating Centre-Research Branch Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
The World Health Organization’s (WHO) new Intersectoral Global Action Plan (IGAP) on Epilepsy and other Neurological Disorders 2022-2031 was adopted by the World Health Assembly on May 2022. This plan represents an integrated approach to neurology and to neurological conditions throughout the life-course and envisions a world in which “brain health is valued, promoted, and protected across the life course; neurological disorders are prevented, diagnosed and treated, and premature mortality and morbidity are avoided; and people affected by neurological disorders and their carers attain the highest possible level of health, with equal rights, opportunities, respect and autonomy”. It also spells out strategic objectives and specific targets, indicators signifying the achievement of these targets, and the means of verification of each indicator. This will mark a turning point for neurological disorders and for neurology and the human race, it will represent a real neurology revolution.
Short Bio
Current Affiliations:
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
Qualifications and memeberships:
Neurologist, Paediatrician, Neonatologist, Child neurologist. Specialized in Bioethics. WFNR Presidium member, EAN board member, EFRR board member, WHO expert on disability and neurology, Corresponding member of the Pontificia Academia Pro Vita. FEAN, Fellow of the European Academy of Neurology. From June 2020 nominated Co-chair of the WHO NeuroCovid Forum–essential neurological services Group, and member of Neuro Covid Global Research Coalition.
Areas Of Interest:
Publications: more than 270 publications on related topics
Awards: Italian excellence for research 2019 – one of the 100 Italian Excellences
